Publication
Phase 3 COVID-19 Vaccines
image credit: CDC
It is very difficult for utility business leaders to plan future projects and resource allocations when they do not know when the COVID-19 Pandemic will end. Currently is seems to be getting worse every day. To make matters worse, as I write this (the last day of July) a hurricane is targeting the southeast U.S. coast, and a significant earthquake has hit Southern California. We are a couple of months away from flu season in the U.S., and wildfire season in California. So planning is very much in limbo.
The only potential good news will be when a COVID-19 Vaccine is available in millions of doses.
What this document attempts to do is define firms and partnerships that have entered Phase 3 trials for their COVID-19 vaccines as of today. I will attempt to only describe products that likely will be available in the U.S. in large volumes before the end of 2020 or early 2021.
Sign in to Participate